Medpace Holdings Valuation
| MEDP Stock | USD 341.82 15.73 4.82% |
At this time, the firm appears to be overvalued. Medpace Holdings secures a last-minute Real Value of $285.97 per share. The latest price of the firm is $341.82. Our model forecasts the value of Medpace Holdings from analyzing the firm fundamentals such as Current Valuation of 10.1 B, profit margin of 0.18 %, and Return On Equity of 0.54 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Medpace Holdings' valuation include:
Price Book 12.0534 | Enterprise Value 10.1 B | Enterprise Value Ebitda 23.0743 | Price Sales 5.1304 | Forward PE 26.2467 |
Overvalued
Today
Please note that Medpace Holdings' price fluctuation is very steady at this time. Calculation of the real value of Medpace Holdings is based on 3 months time horizon. Increasing Medpace Holdings' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Medpace Holdings' intrinsic value may or may not be the same as its current market price of 341.82, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 341.82 | Real 285.97 | Target 269.5 | Hype 341.82 | Naive 321.56 |
The intrinsic value of Medpace Holdings' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Medpace Holdings' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Medpace Holdings helps investors to forecast how Medpace stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Medpace Holdings more accurately as focusing exclusively on Medpace Holdings' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Medpace Holdings' intrinsic value based on its ongoing forecasts of Medpace Holdings' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Medpace Holdings' closest peers.
Medpace Holdings Cash |
|
Medpace Valuation Trend
Medpace Holdings' real value is important for investors to make better decisions and a more accurate overall view of Medpace Holdings' financial worth over time. Using both Medpace Holdings' enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Medpace Revenue by Product
Medpace Holdings Total Value Analysis
Medpace Holdings is now forecasted to have valuation of 10.1 B with market capitalization of 10.62 B, debt of 142.12 M, and cash on hands of 31.01 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Medpace Holdings fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
10.1 B | 10.62 B | 142.12 M | 31.01 M |
Medpace Holdings Investor Information
About 18.0% of the company outstanding shares are owned by corporate insiders. The company has Price/Earnings To Growth (PEG) ratio of 1.63. Medpace Holdings recorded earning per share (EPS) of 11.42. The entity had not issued any dividends in recent years. Based on the key indicators related to Medpace Holdings' liquidity, profitability, solvency, and operating efficiency, Medpace Holdings is performing exceptionally good at this time. It has a great probability to report excellent financial results in December.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 0.12 | 0.1786 |
|
| |||||
| Total Cash From Operating Activities | 455 M | 433.4 M |
|
| |||||
| Operating Income | 353.7 M | 336.8 M |
|
|
Medpace Holdings Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Medpace Holdings has an asset utilization ratio of 113.82 percent. This connotes that the Company is making $1.14 for each dollar of assets. An increasing asset utilization means that Medpace Holdings is more efficient with each dollar of assets it utilizes for everyday operations.Medpace Holdings Ownership Allocation
Medpace Holdings maintains a total of 31.08 Million outstanding shares. The majority of Medpace Holdings outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Medpace Holdings to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Medpace Holdings. Please pay attention to any change in the institutional holdings of Medpace Holdings as this could imply that something significant has changed or is about to change at the company. Also note that almost one million one hundred fourty-three thousand eight hundred three invesors are currently shorting Medpace Holdings expressing very little confidence in its future performance.Medpace Holdings Profitability Analysis
The company reported the previous year's revenue of 1.89 B. Net Income was 282.81 M with profit before overhead, payroll, taxes, and interest of 925.11 M.About Medpace Holdings Valuation
The stock valuation mechanism determines Medpace Holdings' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Medpace Holdings based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Medpace Holdings. We calculate exposure to Medpace Holdings's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Medpace Holdings's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 524.5 M | 278.6 M | |
| Pretax Profit Margin | 0.18 | 0.19 | |
| Operating Profit Margin | 0.18 | 0.12 | |
| Net Profit Margin | 0.15 | 0.16 | |
| Gross Profit Margin | 0.28 | 0.40 |
Medpace Holdings Growth Indicators
Investing in growth stocks can be very risky. If the company such as Medpace Holdings does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 31.8 M | |
| Quarterly Earnings Growth Y O Y | 0.356 | |
| Forward Price Earnings | 26.2467 |
Medpace Holdings Current Valuation Indicators
Medpace Holdings' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Medpace Holdings' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Medpace Holdings, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Medpace Holdings' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Medpace Holdings' worth.Additional Tools for Medpace Stock Analysis
When running Medpace Holdings' price analysis, check to measure Medpace Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medpace Holdings is operating at the current time. Most of Medpace Holdings' value examination focuses on studying past and present price action to predict the probability of Medpace Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medpace Holdings' price. Additionally, you may evaluate how the addition of Medpace Holdings to your portfolios can decrease your overall portfolio volatility.